Recurrent and Metastatic Non-Small Cell Lung Cancer

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


This chapter provides answers to practice-based questions with case studies covering the new principles of diagnosis, classification, staging, treatment, and outcomes in the rapidly advancing field of recurrent and metastatic non-small cell lung cancer. Lung cancer remains the leading cause of cancer related deaths worldwide. The number of new lung cancer cases and lung cancer–related deaths continues to decrease each year due to improved smoking cessation rates and implementation of lung cancer screening programs as well as substantial therapeutic advances. Immunotherapy has revolutionized treatment for patients with recurrent and metastatic non-small cell lung cancer without actionable mutations. The chapter also provides expert guidance in the areas of cancer-related uncertainties and controversies, including experience-based discussions.

Original languageEnglish
Title of host publicationCancer Consult
Subtitle of host publicationExpertise in Clinical Practice, Volume 1: Solid Tumors and Supportive Care
Number of pages18
ISBN (Electronic)9781119823766
ISBN (Print)9781119823735
StatePublished - Jan 1 2023


  • Immunotherapy
  • Lung cancer screening programs
  • Lung cancer–related deaths
  • Non-small cell lung cancer


Dive into the research topics of 'Recurrent and Metastatic Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this